Manhattan West Asset Management LLC purchased a new stake in Avantor, Inc. (NYSE:AVTR - Free Report) in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 224,212 shares of the company's stock, valued at approximately $2,220,000.
Several other hedge funds and other institutional investors have also recently made changes to their positions in AVTR. EverSource Wealth Advisors LLC boosted its stake in Avantor by 119.1% during the second quarter. EverSource Wealth Advisors LLC now owns 2,187 shares of the company's stock worth $29,000 after buying an additional 1,189 shares during the last quarter. Private Trust Co. NA increased its stake in Avantor by 46.2% during the fourth quarter. Private Trust Co. NA now owns 2,769 shares of the company's stock worth $32,000 after acquiring an additional 875 shares during the last quarter. Strategic Wealth Investment Group LLC purchased a new stake in Avantor in the second quarter valued at $32,000. Los Angeles Capital Management LLC purchased a new stake in Avantor in the fourth quarter valued at $32,000. Finally, Osaic Holdings Inc. lifted its stake in shares of Avantor by 60.9% in the 2nd quarter. Osaic Holdings Inc. now owns 2,810 shares of the company's stock valued at $38,000 after purchasing an additional 1,064 shares during the last quarter. Institutional investors and hedge funds own 95.08% of the company's stock.
Avantor Stock Performance
Shares of AVTR stock opened at $14.45 on Friday. The firm has a 50 day moving average of $11.63 and a two-hundred day moving average of $9.65. The stock has a market capitalization of $9.77 billion, a PE ratio of -17.20, a P/E/G ratio of 10.76 and a beta of 0.89. The company has a quick ratio of 1.18, a current ratio of 1.78 and a debt-to-equity ratio of 0.65. Avantor, Inc. has a 52 week low of $7.26 and a 52 week high of $15.93.
Avantor (NYSE:AVTR - Get Free Report) last posted its quarterly earnings data on Wednesday, July 29th. The company reported $0.21 earnings per share for the quarter, topping analysts' consensus estimates of $0.19 by $0.02. The business had revenue of $1.69 billion for the quarter, compared to analyst estimates of $1.61 billion. Avantor had a positive return on equity of 9.92% and a negative net margin of 8.81%.The company's revenue was up .5% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.24 earnings per share. Avantor has set its FY 2026 guidance at 0.800-0.830 EPS. On average, research analysts predict that Avantor, Inc. will post 0.81 EPS for the current fiscal year.
Analyst Ratings Changes
A number of equities analysts have recently weighed in on the company. Citigroup increased their price target on Avantor from $9.00 to $11.00 and gave the stock a "neutral" rating in a report on Wednesday, July 8th. Barclays boosted their price objective on shares of Avantor from $7.00 to $8.00 and gave the company an "underweight" rating in a report on Wednesday, June 24th. Zacks Research raised shares of Avantor from a "strong sell" rating to a "hold" rating in a research note on Thursday, April 30th. Wolfe Research upgraded shares of Avantor from a "strong sell" rating to a "hold" rating in a research report on Thursday, July 30th. Finally, Deutsche Bank Aktiengesellschaft reissued a "hold" rating and issued a $13.00 price target on shares of Avantor in a research note on Thursday, July 30th. Two equities research analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and one has assigned a Sell rating to the company's stock. According to data from MarketBeat, the stock currently has an average rating of "Hold" and an average price target of $12.00.
Check Out Our Latest Research Report on Avantor
Avantor Company Profile
(
Free Report)
Avantor, Inc NYSE: AVTR is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.
Avantor's offerings are organized across two primary segments.
See Also
Want to see what other hedge funds are holding AVTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Avantor, Inc. (NYSE:AVTR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Avantor, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Avantor wasn't on the list.
While Avantor currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.